Aytu Biopharma (AYTU) Raw Materials (2019 - 2026)

Aytu Biopharma (AYTU) has 8 years of Raw Materials data on file, last reported at $1.4 million in Q1 2026.

• On a quarterly basis, Raw Materials rose 155.49% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 155.49% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 319.17% from the prior year.
• Raw Materials for Q1 2026 stood at $1.4 million, up from $1.2 million in the prior quarter.
• Over the last five years, Raw Materials for AYTU reached as high as $2.2 million in Q1 2023 and fell as low as $266000.0 in Q2 2024.
• Historically, Raw Materials has averaged $1.4 million across 5 years, with a median of $1.4 million in 2025.
• Across the five-year window, Raw Materials plunged 79.55% in 2024 and surged 319.17% in 2025, its largest moves.
• Year by year, Raw Materials stood at $1.8 million in 2022, then slipped by 7.39% to $1.7 million in 2023, then slumped by 70.13% to $494000.0 in 2024, then surged by 144.94% to $1.2 million in 2025, then gained by 13.39% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $1.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.